Getein Biotech, Inc.SSE: 603387

(603387)"Getein Biotech, Inc"Report for Q3 2026

Oct 28, 2026 · Issued by Getein Biotech, Inc. via Shanghai Stock Exchange

Filed with SSE · Stock code 603387 · Oct 28, 2026

On 6ix: 6ix.com/news/603387getein-biotech-increport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Getein Biotech, Inc. on 6ix

Earlier from Getein Biotech

(603387)"Getein Biotech, Inc."Announcement on Progress in Repurchasing Shares through Call AuctionOct 10
Announcement on Outline of the 2026 Semi-annual Online Performance BriefingSep 16
Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026Sep 12
Announcement on Obtaining a Commitment Letter for a Special Loan for Share Repurchase from a Financial InstitutionSep 1
Announcement on Resolutions of the 14th Meeting of the 4th Board of DirectorsAug 27

All Getein Biotech news releases

Follow Getein Biotech into a list and get an email when it puts out news.

Follow Getein Biotech